GRIA4 Human shRNA Plasmid Kit (Locus ID 2893)

Specifications

Product Data
Product Name	GRIA4 Human shRNA Plasmid Kit (Locus ID 2893)
Locus ID	2893
UniProt ID	P48058
Synonyms	GluA4; GluA4-ATD; GLUR4; GLUR4C; GLURD; NEDSGA
Vector	pGFP-V-RS
Format	Retroviral plasmids
Kit Components	GRIA4 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 2893). 5µg purified plasmid DNA per construct 29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free.
RefSeq	NM_000829, NM_001077243, NM_001077244, NM_001112812, NR_046356, NM_001077244.1, NM_000829.1, NM_000829.2, NM_000829.3, NM_001077243.1, NM_001077243.2, NM_001112812.1, BC015199, BC035610, BC045546, BC114549, BC142654, BC146816, BC150209, BC167786, BM675457, BM723114, NM_001112812.2, NM_001077244.2
Summary	Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing of this gene results in transcript variants encoding different isoforms, which may vary in their signal transduction properties. Some haplotypes of this gene show a positive association with schizophrenia. [provided by RefSeq, Jul 2008]
shRNA Design	These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed	OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.